Global mergers and acquisitions activity sinks in 2022 Mergers and acquisitions activity globally fell well short of the high-water mark set last year as debt financing markets collapsed and stock market volatility decimated … Business • 21 Dec 22
Amgen to buy Horizon Therapeutics for $27.8 billion Amgen has today agreed to buy Dublin headquartered Horizon Therapeutics in a deal valued at $27.8 billion, fortifying its rare diseases portfolio amid pressure on … Business • 21 Dec 22
Amgen in advanced talks to buy Horizon Therapeutics Amgen is in advanced talks to buy Dublin headquartered biotech company Horizon Therapeutics, the Wall Street Journal reported today, while rival bidder French health group … Business • 12 Dec 22
Horizon Therapeutics in sale talks with three firms Horizon Therapeutics has said its board is engaged in highly preliminary discussions with three pharmaceutical giants for potential takeover offers, sending its shares surging 31% … Business • 30 Nov 22
Amgen invests $100m in Dun Laoghaire plant Amgen is investing $100m today in the construction of a new vial filing line with new technology and site infrastructure at its manufacturing plant in … Business • 21 Dec 21
